Psychedelics Optimi Health submits clinical trial application after developing proprietary MDMA drug The drug will be used to help establish a safe supply for patients in Canada and Australia Rowan DunneFebruary 7, 2023
Psychedelics Woke Pharma and Swinburne U partner for Australia’s biggest psilocybin trial The AUD$5M study will involve about 160 participants and aims to help combat treatment-resistant depression Rowan DunneFebruary 1, 2023
Canada Health Canada provides guidance for clinical trials on psychedelics The notice to stakeholders outlined risk management and consent expectations for the study of psychoactive drugs Rowan DunneDecember 5, 2022
Health & Wellness ChitogenX completes opening phases of rotator cuff clinical trial ChitogenX is a clinical stage regenerative medicine company developing therapeutic tissue repair technologies. Joseph MortonNovember 9, 2022
Psychedelics Small Pharma gets approval for upcoming injectable DMT trial on humans New phase I study will be held at MAC Clinical Research in Manchester, England next year Rowan DunneOctober 31, 2022
Medical and Pharmaceutical The Mugglehead technology roundup: medical tech and biotechnology edition Here are five biotechnology and medical tech companies pooling their resources to make our lives easier. Joseph MortonOctober 14, 2022
Medical and Pharmaceutical Immunic secures private funding for clinical stage studies Immunic is a biopharmaceutical company that engages in clinical-stage studies involving a pipeline of oral immunology therapies Joseph MortonOctober 11, 2022
Sleep Not sleeping enough has negative impacts on immune function: NIH Researchers studied how sleep disruptions in humans and mice increased levels of immune stem cell production and circulation in bone marrow. Joseph MortonSeptember 21, 2022
Canada ATMA receives Health Canada approval for new psilocybin trial Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic Rowan DunneSeptember 15, 2022
International PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies Organization to supply GMP product for second major clinical trial down under this month Rowan DunneAugust 31, 2022